Verona Pharma shareholders approve $10 billion Merck acquisition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. AKAM
2. COST
3. SPY
4. ZS
5. META
6. NVDA
7. DRI
8. ULS
9. PRME
10. CRL

Go back to Verona Pharma shareholders approve $10 billion Merck acquisition
Merck & Co. (NYSE: MRK) Delayed: 148.48 +0.50 (0.34%)
Previous Close $147.98    52 Week High $65.46 
Open $148.06    52 Week Low $47.97 
Day High $149.98    P/E 101.01 
Day Low $147.67    EPS $1.47 
Volume 1,387,199       

(NASDAQ: VRNA) Delayed: 106.91 --0 (-0%)
Previous Close $106.91    52 Week High $ 
Open $106.91    52 Week Low $ 
Day High $106.91    P/E N/A 
Day Low $106.91    EPS $ 
Volume 159,323